The nation of Zimbabwe has declined a major US health deal valued at $367m (272 million pounds) spanning five years due to Washington's insistence on sensitive information.
The decision came to light following a government memo dated December was leaked, revealing that Head of State Emmerson Mnangagwa believed the deal was "skewed".
An official spokesman has since explained that the US was seeking biological samples for scientific study and commercial gain while was not willing to guarantee the resulting advantages from future medical innovations.
"We must now begin the difficult and regrettable process of scaling back our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had furnished more than $1.9bn in health funding to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has called for further negotiations to find a agreement suitable to both sides so the country's critical HIV treatment initiative can be sustained.
Broader Background
Zimbabwe's decision follows a comparable case in Kenya, where a high court blocked a related health funding agreement after legal challenges were filed about the safety of citizens' medical information.
Since resuming the presidency last year, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.
The agency had administered aid for the US government, but Trump claimed its expenditure was "wasteful" and his administration was seeking direct bilateral agreements to boost transparency and responsibility.
According to statements, Sixteen nations in Africa have so far signed similar health pacts, constituting more than $18.3bn in committed funds.
Details of the Declined Agreement
The funds for Zimbabwe would have funded "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".
"We are confident this cooperation might have yielded significant benefits for the people of Zimbabwe, especially the 1.2 million men, women and children presently on HIV treatment through American-funded initiatives," the Ambassador commented.
However, government spokesperson Nick Mangwana said the proposed deal was "unfair".
"Zimbabwe was being asked to surrender its genetic material and health information indefinitely, without any corresponding assurance of access to any medical innovations – such as new medicines or tests – that might result from that provided information," Mangwana explained.
"Put simply, our country would supply the raw materials for medical research with no certainty that the resulting innovations would be available to our people if a new disease outbreak emerge."
National Interest and International Frameworks
Mangwana further noted that the American exit from the World Health Organization (WHO) and its push of bilateral deals were undermining systems previously established via the international organization.
The spokesperson gave as an example its Pandemic Benefit-Sharing scheme designed to deal with future global health emergencies.
"This system is designed to ensure that when a country provides its information, the benefits – including medicines and cures – are shared equitably, not monopolised solely by those with the capability to develop them."
The government's concerns regarding the US deal "should not be misconstrued as opposition to America," he added.
"We encourage ongoing dialogue with our American counterparts on how subsequent co-operation might be designed in a way that respects the independence and interests of each country."
Medical Community Reaction
A leading public health body said it understood the government's concerns, but suggested that talks must proceed given that a large portion of the nation's Aids initiatives were funded by external financing.
"Where specific concerns arise, including those relating to information security or implementation frameworks, these can often be addressed via detailed discussion and mutually agreed protections," the group commented.
This impasse emphasises the continuing debate between accepting crucial international aid and protecting local interests in an increasingly interconnected world.